Literature DB >> 11860503

Gelatinase B and TIMP-1 are regulated in a cell- and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia.

Santiago Rivera1, Crystel Ogier, Jérôme Jourquin, Serge Timsit, Arkadius W Szklarczyk, Karen Miller, Andrew J H Gearing, Leszek Kaczmarek, Michel Khrestchatisky.   

Abstract

Matrix metalloproteinases (MMPs) belong to a large family of endopeptidases that regulate the pericellular environment through the cleavage of protein components of the extracellular matrix, membrane receptors and cytokines. MMP activity is controlled by the multifunctional tissue inhibitors of metalloproteinases (TIMPs). Proteases and their inhibitors are critically involved in developmental and pathological processes in numerous organs, including the brain. Global transient cerebral ischemia induces selective delayed neuronal death and neuroinflammation. We compared, in discrete vulnerable and resistant areas of the ischemic rat hippocampus, the kinetics and cellular distribution of gelatinase B and its principal inhibitor TIMP-1 and we assessed by in situ zymography, the net gelatinolytic activity at the cellular level. We show that gelatinases are expressed and active in neurons, suggesting that MMPs play a role in maintaining neural homeostasis. In the ischemic rat brain, expression and activity of gelatinase B, and expression of TIMP-1 are altered in a time-, region- and cell-dependent manner. Gelatinase B is induced first in reactive microglia and subsequently in reactive astrocytes. In situ, increases in gelatinase activity accompanied the progression of neuronal death and glial reactivity. Our results suggest that MMPs and TIMPs are involved in cell viability and tissue remodelling in the ischemic brain, and reinforces the idea that the MMP/TIMP system contributes both to neuronal demise and tissue repair in the context of glial reactivity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860503     DOI: 10.1046/j.0953-816x.2001.01838.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  38 in total

1.  Expression of MMP2, MMP9 and MMP3 in breast cancer brain metastasis in a rat model.

Authors:  Odete Mendes; Hun-Taek Kim; George Stoica
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

2.  Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference.

Authors:  Travis E Brown; Melissa R Forquer; Davelle L Cocking; Heiko T Jansen; Joseph W Harding; Barbara A Sorg
Journal:  Learn Mem       Date:  2007-03-09       Impact factor: 2.460

3.  Matrix metalloproteinase 9 expression: new regulatory elements.

Authors:  Irina Surgucheva; Kumaravel Chidambaram; David A Willoughby; Andrei Surguchov
Journal:  J Ocul Biol Dis Infor       Date:  2010-08-05

Review 4.  Matrix metalloproteinases in the adult brain physiology: a link between c-Fos, AP-1 and remodeling of neuronal connections?

Authors:  Leszek Kaczmarek; Joanna Lapinska-Dzwonek; Sylwia Szymczak
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

5.  The involvement of matrix metalloproteinases 2 and 9 in rat retinal ischemia.

Authors:  Nurit Mathalone; Nitza Lahat; Michal A Rahat; Keren Bahar-Shany; Yoram Oron; Orna Geyer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-10-06       Impact factor: 3.117

6.  HIV-1 gp120-induced injury to the blood-brain barrier: role of metalloproteinases 2 and 9 and relationship to oxidative stress.

Authors:  Jean-Pierre Louboutin; Lokesh Agrawal; Beverly A S Reyes; Elisabeth J Van Bockstaele; David S Strayer
Journal:  J Neuropathol Exp Neurol       Date:  2010-08       Impact factor: 3.685

7.  Systemic inflammation following hind-limb ischemia-reperfusion affects brain in neonatal mice.

Authors:  M Daniela Bianco-Batlles; Alexander Sosunov; Richard A Polin; Vadim S Ten
Journal:  Dev Neurosci       Date:  2008-10-15       Impact factor: 2.984

8.  Cortical spreading depression activates and upregulates MMP-9.

Authors:  Yasemin Gursoy-Ozdemir; Jianhua Qiu; Norihiro Matsuoka; Hayrunnisa Bolay; Daniela Bermpohl; Hongwei Jin; Xiaoying Wang; Gary A Rosenberg; Eng H Lo; Michael A Moskowitz
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

9.  Low-dose candesartan enhances molecular mediators of neuroplasticity and subsequent functional recovery after ischemic stroke in rats.

Authors:  Tauheed Ishrat; Bindu Pillai; Sahar Soliman; Abdelrahman Y Fouda; Anna Kozak; Maribeth H Johnson; Adviye Ergul; Susan C Fagan
Journal:  Mol Neurobiol       Date:  2014-08-02       Impact factor: 5.590

10.  A new role for TIMP-1 in modulating neurite outgrowth and morphology of cortical neurons.

Authors:  Adlane Ould-yahoui; Evelyne Tremblay; Oualid Sbai; Lotfi Ferhat; Anne Bernard; Eliane Charrat; Yatma Gueye; Ngee Han Lim; Keith Brew; Jean-Jacques Risso; Vincent Dive; Michel Khrestchatisky; Santiago Rivera
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.